61 related articles for article (PubMed ID: 9564204)
1. Clozapine reduces rehospitalization among schizophrenia patients.
Pollack S; Woerner MG; Howard A; Fireworker RB; Kane JM
Psychopharmacol Bull; 1998; 34(1):89-92. PubMed ID: 9564204
[TBL] [Abstract][Full Text] [Related]
2. The pharmacoeconomics of clozapine: a review.
Meltzer HY; Cola PA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564
[TBL] [Abstract][Full Text] [Related]
3. New vs. old antipsychotics: the Texas experience.
Reid WH
J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
[TBL] [Abstract][Full Text] [Related]
4. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
Kim JH; Kim D; Marder SR
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
[TBL] [Abstract][Full Text] [Related]
5. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
7. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
8. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
[TBL] [Abstract][Full Text] [Related]
9. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Bobo WV; Jayathilake K; Lee MA; Meltzer HY
Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
[TBL] [Abstract][Full Text] [Related]
10. Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatients.
Stieffenhofer V; Saglam H; Schmidtmann I; Silver H; Hiemke C; Konrad A
Pharmacopsychiatry; 2011 Mar; 44(2):55-9. PubMed ID: 21207352
[TBL] [Abstract][Full Text] [Related]
11. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
[TBL] [Abstract][Full Text] [Related]
12. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
13. Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics.
Mäkikyrö T; Leinonen E; Koponen H; Järvelin MR; Hakko H; Saarnisaari O; Isohanni M
J Psychiatr Res; 1998; 32(2):105-10. PubMed ID: 9694006
[TBL] [Abstract][Full Text] [Related]
14. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
Nielsen J; Nielsen RE; Correll CU
J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
[TBL] [Abstract][Full Text] [Related]
15. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
16. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
[TBL] [Abstract][Full Text] [Related]
17. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
Sun SX; Liu GG; Christensen DB; Fu AZ
Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
[TBL] [Abstract][Full Text] [Related]
18. [Atypical neuroleptics and selective attention].
Stip E; Lussier I; Lalonde P; Luyet A; Fabian J
Encephale; 1999; 25(3):260-4. PubMed ID: 10434152
[TBL] [Abstract][Full Text] [Related]
19. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
20. Ethnic comparisons of antipsychotic use in schizophrenia.
Wheeler A; Humberstone V; Robinson E
Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
